{"id":"W2594151149","doi":"10.1182/blood.v108.11.367.367","title":"Kinetin Riboside Is a Novel Targeted Inhibitor of CCND1 and CCND2 Transactivation with Substantial Preclinical Anti-Myeloma Activity.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D2; Cyclin D1; Transactivation; Cancer research; Biology; Cyclin B1; Cyclin D; Cyclin A; Cell cycle; Cyclin; Molecular biology; Biochemistry; Genetics; Gene expression; Cancer; Cyclin-dependent kinase 1; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008242859,0.0004069407,0.0002308938,0.0003140099,0.0001588262,0.0001708865,0.0002464156,0.0002477978,0.00177573],"category_scores_gemma":[0.00006035841,0.0001161319,0.0001427597,0.0002130528,0.0001254549,0.0001178064,0.0001025566,0.0004447558,0.0003236292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004599839,"about_ca_system_score_gemma":0.0002495064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001853972,"about_ca_topic_score_gemma":0.007381464,"domain_scores_codex":[0.9999607,0.000004869569,0.000002459648,0.000008863734,0.00001195892,0.00001120674],"domain_scores_gemma":[0.9999661,0.000005269925,0.000007990581,0.000004309921,0.000004487314,0.00001174484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007065426,0.0003153609,0.0002239752,0.0001596491,0.00002363928,0.0001007397,0.00001995362,0.0003821563,0.9829012,0.0002171704,0.0006686519,0.0142811],"study_design_scores_gemma":[0.0007839044,0.00887122,0.008245208,0.00003053377,0.00008095834,0.001005645,0.00002213189,0.001126218,0.9569696,0.0000973717,0.02274703,0.00002005422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9644945,0.01520449,0.00480336,0.0003907178,0.00009844838,0.0004610741,0.002559821,0.0005209894,0.01146665],"genre_scores_gemma":[0.9800096,0.006110858,0.003476291,0.0001110591,0.00001608778,0.0001401508,0.003095927,0.00002698207,0.007013085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001853972,"threshold_uncertainty_score":0.005940437,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02151680708679548,"score_gpt":0.2839931647472843,"score_spread":0.2624763576604888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}